A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
Atavistik Bio, Inc
Atavistik Bio, Inc
Alterome Therapeutics, Inc.
UMC Utrecht
City of Hope Medical Center
M.D. Anderson Cancer Center
Medstar Health Research Institute
Stanford University
East and North Hertfordshire NHS Trust